01.06.2023 Views

2022 Annual Report

This is the 2022 Annual Report for Van Andel Institute.

This is the 2022 Annual Report for Van Andel Institute.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

large-scale, collaborative projects designed to shed new<br />

light onto cancer, Parkinson’s, rare disorders and many<br />

other diseases.<br />

Brian Haab, Ph.D.<br />

Professor<br />

Dr. Brian Haab searches for new ways<br />

to diagnose and stratify pancreatic<br />

cancers based on the chemical<br />

fingerprints tumors leave behind. Part<br />

of the problem Dr. Haab aims to solve<br />

is that cancers often look and behave normally — until after<br />

they’ve started making people sick. Dr. Haab is sleuthing<br />

out clues to build a library of diagnostic tools that will help<br />

providers diagnose tumors earlier and optimize treatment.<br />

Matt Steensma, M.D.<br />

Associate Professor<br />

Dr. Matt Steensma studies the<br />

genetic and molecular factors that<br />

cause benign tumors to become<br />

cancers, in search of vulnerabilities<br />

that may be targeted for treatment.<br />

As a scientist at VAI and a practicing surgeon at Corewell<br />

Health Helen DeVos Children’s Hospital, he is committed<br />

to translating scientific discoveries into treatments that<br />

improve patients’ lives.<br />

Bart Williams, Ph.D.<br />

Director, Core Technologies and Services;<br />

Professor<br />

Dr. Bart Williams studies the building<br />

blocks of bone growth on behalf of<br />

the millions suffering from diseases<br />

such as osteoporosis. He seeks<br />

new ways of altering cell signaling pathways to encourage<br />

healthy bone development and deter cancer spread to the<br />

skeleton. Dr. Williams also serves as director of VAI’s Core<br />

Technologies and Services, which provide technology<br />

and specialized expertise to Institute scientists and<br />

collaborators.<br />

Two VAI scientists named to elite Highly Cited<br />

Researchers list<br />

Dr. Russell Jones and Dr. Peter W. Laird were included in the<br />

<strong>2022</strong> Clarivate Highly Cited Researchers list, a distinction<br />

marking them as leaders in their fields. The greatly anticipated<br />

annual list identifies researchers who demonstrated<br />

significant influence in their chosen area or areas of study<br />

through the publication of multiple highly cited papers during<br />

the last decade. Their names are drawn from the publications<br />

that rank in the top 1% by citations for field and publication<br />

year in the Web of Science citation index.<br />

Citations, or references to a scientist’s<br />

published work by other researchers,<br />

are universally considered a<br />

Around<br />

the<br />

Institute<br />

measure of influence and impact<br />

in the scientific community. Jones<br />

studies how diet and metabolism<br />

impact the immune system’s<br />

ability to fight infection and<br />

cancer. Laird investigates the<br />

role of epigenetics in cancer.<br />

Both were included on the<br />

2021 list.<br />

Craig Reynolds joins VAI as Vice President for<br />

Research Protections<br />

In fall <strong>2022</strong>, VAI appointed Craig Reynolds as Vice President<br />

for Research Protections following a national search. Reynolds<br />

joined VAI from University of Michigan, where he most<br />

recently served as Assistant Vice President for Research-<br />

Sponsored Projects. He was hired during an exceptional<br />

period of growth in our organization.<br />

Since 2014, the Institute has recruited more than two dozen<br />

principal investigators who have established labs at VAI and<br />

expanded our research into new areas including metabolism<br />

and nutrition.<br />

RESEARCH<br />

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!